Crossmark

Evaluation of circulating glypican 4 as a novel biomarker in disease – A comprehensive review

Published Online: 2025-02-17

Published Print: 2025-04

Authors

Muendlein, A. https://orcid.org/0000-0002-5582-4125
Leiherer, A.

Drexel, H.
License Information

Text and Data Mining valid from 2025-02-17

Version of Record valid from 2025-02-17
More Information

Article History

Received: 3 October 2024

Revised: 18 November 2024

Accepted: 18 January 2025

First Online: 17 February 2025

Declarations

:

: Not applicable.

: The authors have no relevant financial or non-financial interests to disclose.

Document is current